BMBruno Costa Martins

Bruno Costa Martins

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bruno Costa Martins has a total of 282 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endoscopic resection of duodenal neuroendocrine tumors: safety and long-term oncologic outcomes

    by Bruno da Costa Martins, Larissa Mercadante de Assis, Andre Roncon Dias, Rodrigo Corsato Scomparin, Luciano Lenz, Renata Nobre Moura, Adriana Vaz Saflate-Ribeiro, Fauze Maluf-Filho

  • Open Access

    Clinical outcomes of plastic versus self-expanding metal stents in malignant hilar biliary obstruction

    by Pastor Joaquín Ortiz Mendieta, Bruno da Costa Martins, Deborah Marques Centeno, Julia Mayumi Gregorio, Rafael Utimura Sueta, Adriana Vaz Safatle Ribeiro, Caterina Maria Pia Simoni Pennacchi, Carla Cristina Gusmon, Gustavo Andrade de Paulo, Luciano Henrique Lenz Tolentino, et al.

    Background: Malignant hilar biliary obstruction (MHBO) is a challenging condition with a poor prognosis, often requiring palliative biliary drainage. Endoscopic placement of plastic stents (PS) or self-expanding metal stents (SEMS) are the preferred approaches, but the optimal choice remains under debate. This study compares the clinical outcomes, patency, and survival associated with PS and SEMS in patients with unresectable MHBO. Methods: This retrospective study analyzed patients with MHBO who underwent endoscopic drainage between January 2015 and December 2022 at a tertiary cancer center. Clinical success, stent patency, survival, and reintervention rates were compared between patients receiving PS or SEMS. Cox proportional hazards models and Kaplan–Meier survival analyses were used to evaluate outcomes. Results: A total of 86 patients were included, with 39 (45.3%) receiving SEMS and 47 (54.7%) receiving PS. Clinical success was higher in the SEMS group (76.9% vs. 51.1%; p = 0.015), but this association was not confirmed in multivariate analysis. SEMS demonstrated significantly longer patency (median 213 vs. 78 days; p = 0.01) and a lower risk of recurrent biliary obstruction (HR 3.17, 95% CI 1.60–6.27; p = 0.001). However, overall survival did not differ significantly between groups (p = 0.059). Multivariate analysis identified better ECOG status (0–2) and bilirubin levels < 10 mg/dL as independent predictors of clinical success and longer survival. Conclusion: SEMS provide superior patency compared to PS but did not significantly impact overall survival. Clinical success was influenced by ECOG performance status and baseline bilirubin levels rather than stent type alone.

  • Open Access

    Prophylaxis of esophageal stricture after endoscopic submucosal dissection with autologous adipose-derived stromal cells

    by Ylanna Fortes, Renata Nobre, Bruno da Costa Martins, Luciano Lenz, Adriana Vaz Safatle-Ribeiro, Cristina Pires Camargo, Fauze Maluf-Filho

  • Randomized trial of intralesional steroid injection versus oral prednisolone for preventing esophageal stricture after extensive endoscopic submucosal dissection

    by Joel Fernandez de Oliveira, Bruno Costa Martins, Renata Nobre Moura, Gustavo Andrade de Paulo, Luciano Lenz, Marcelo Simas de Lima, Adriana Vaz Safatle-Ribeiro, Fauze Maluf-Filho

    Summary: Endoscopic submucosal dissection (ESD) is the preferred treatment for early esophageal neoplasms. However, ESD involving more than three-quarters of the esophageal circumference often leads to stricture formation. While corticosteroids are widely used to prevent strictures, the optimal route of administration remains unclear. This study aimed to compare submucosal corticosteroid injection (IC) with oral corticosteroid administration (OC) in decreasing the number of dilations required for stricture resolution, stricture rate, and stricture resolution rate. This was a single-center, open-label, randomized clinical trial. Thirty patients with esophageal mucosal defects involving more than three-quarters of the esophageal circumference were enrolled and randomly assigned to two groups. The IC group received 100 mg of triamcinolone injected into the resection bed immediately after the procedure. The OC group was given oral prednisolone starting 3 days post-ESD, initially at 30 mg/day, tapered over 8 weeks. A total of 30 patients were included, 15 in each group. The OC group required significantly fewer dilation sessions than the IC group (5 vs. 19; P = 0.04). However, the stricture rate was similar between the groups (OC: 66.7% vs. IC: 40%; P = 0.27), as well as the stricture resolution rate (OC: 50% vs. IC: 40%; P > 0.99). No significant differences were observed in other adverse events or blood glucose levels between the groups. Oral corticosteroids resulted in fewer dilation sessions to resolve strictures after extensive esophageal ESD compared to intralesional injections. No differences were observed in stricture rates or other adverse events between the two groups. ClinicalTrials.gov (NCT04498260).

  • Open Access

    Impact of Sedation Regimen on Diagnostic Adequacy in Endoscopic ultrasonography-Guided Tissue Acquisition of Solid Pancreatic Lesions

    by Luciano Lenz, Silvia Kim, Bruno Martins, Leika Miyahara Felipe, Sergio Eiji Matuguma, Andressa Abnader Machado, Renata Nobre, Marcelo Simas de Lima, Gustavo Andrade de Paulo, Adriana Vaz Safatle-Ribeiro, et al.

    Background and study aim Endoscopic ultrasonography-guided tissue acquisition (EUS-TA) requires patient cooperation for optimal tissue yield. Sedation improves comfort and procedural conditions, but the impact of different sedation strategies on tissue adequacy is unclear. This study compared balanced propofol sedation (BPS) versus general anesthesia (GA) for EUS-TA of solid pancreatic lesions (SPLs) using propensity score matching (PSM). Patients and methods Single-center, cohort study with retrospective analysis of a prospectively collected database. All patients undergoing EUS-TA for SPL from April 2013 to February 2025 were included. Standalone EUS was performed under BPS; combined EUS-ERCP procedures under GA. Anesthetist-assisted (AS) deep sedation (without intubation) was classified as. Adequacy was defined as sufficient material for cytologic/histologic interpretation (inadequate if only blood or epithelial cells). Direct comparisons, multivariable logistic regression, and PSM were performed. Results In all, 491 EUS-TA procedures in 433 patients (50.3% female) were performed; the overall adequacy was 85.7%. BPS was used in 370 (74.5%, adequacy 84.6%), GA in 93 (18.9%, 89.2%), and AS in 28 (5.7%, 89.3%) (p = 0.448). No significant difference between BPS and GA (p = 0.256) or endoscopist-directed (BPS) vs. anesthetist-directed sedation (GA + AS) (p = 0.209). Multivariable regression (adjusted for needle type, diagnosis, lesion location) showed no association of sedation method with adequacy (GA vs. BPS: p = 0.565). After PSM (needle type, adenocarcinoma, pancreatic head lesions), no significant differences emerged across modalities. Conclusions In this large real-world cohort, BPS achieved comparable adequacy to GA for EUS-TA of SPL. Deeper sedation does not appear to improve adequacy in tertiary centers. Prospective studies on safety and cost-effectiveness are needed.

    • 9 January 2026
      • Vol. 62, e25057
    Open Access

    FIRST BRAZILIAN CONSENSUS ON CHOLANGIOPANCREATOSCOPY BY THE BRAZILIAN SOCIETY OF DIGESTIVE ENDOSCOPY (SOBED).

    by Tomazo Antônio Prince Franzini, Bruno da Costa Martins, Alexandre Moraes Bestetti, Carlos Henrique Barros Amaral, Cláudio Rogério Solak, Djalma Ernesto Coelho Neto, Eduardo Guimarães Hourneaux DE Moura, Eduardo Michels Oppitz, Fernanda Prata Martins, Flavio Hayato Ejima, et al.

    Despite the widespread adoption of single-operator cholangiopancreatoscopy for the management of biliary and pancreatic diseases, this method was recently introduced in Brazil. This study aimed to develop a Brazilian consensus for the diagnostic and therapeutic use of single-operator cholangiopancreatoscopy for the management of pancreatobiliary diseases. A working group from the Brazilian Society of Digestive Endoscopy (SOBED) specialists, using a Delphi methodology, formulated statements across six topics: indeterminate biliary strictures, complex biliary stones, primary sclerosing cholangitis, peroral pancreatoscopy, post-liver transplantation, and antibiotic prophylaxis. Eighteen experts evaluated these statements using an anonymous electronic voting system. Consensus was defined as ≥80% agreement. Eighteen statements were formulated and voted on by a panel of experts to reach a consensus. The panel consisted of 18 endoscopy specialists from various regions of Brazil, with an average of 20.4 years of experience. Consensus was achieved on all statements in the first round. These recommendations establish the role of cholangiopancreatoscopy in diagnostic and therapeutic for indeterminate biliary strictures, complex biliary stones, primary sclerosing cholangitis, peroral pancreatoscopy, post-liver transplantation, and antibiotic prophylaxis, providing a background for its standardized use in Brazil.

  • Open Access

    INTEROBSERVER AGREEMENT OF INTRAPAPILLARY CAPILLARY LOOPS CLASSIFICATION FOR SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN A WESTERN CENTER

    by Fauze Maluf-Filho, Ossamu Okazaki, Beanie Conceição Medeiros Nunes, Adriana Vaz Safatle-Ribeiro, Luciano Lenz, Bruno Costa Martins

    Background: Accurate evaluation of the invasion depth of superficial esophageal squamous cell carcinoma (SESCC) is crucial for optimal treatment. While magnifying endoscopy (ME) using the Japanese Esophageal Society (JES) classification is reported as the most accurate method to predict invasion depth, its efficacy has not been tested in the Western world. This study aims to evaluate the interobserver agreement of the JES classification for SESCC and its accuracy in estimating invasion depth in a Brazilian tertiary hospital. Methods: We retrospectively selected ME with Narrow Band Imaging (ME-NBI) images of 30 suspected SESCC cases. The best images of each case were included in online forms, which were evaluated by ten endoscopists (five experts and five novices). The evaluators classified the lesions according to the JES-IPCL classification and estimated the depth of invasion. Interobserver agreement was assessed using kappa values. Histological comparison was possible for 17 lesions. Results: The overall interobserver agreement for the JES-IPCL classification was moderate (K=0.455, P<0.001). Agreement among experts (K=0.437) and novices (K=0.483) was also moderate. Sensitivity, specificity, and accuracy for IPCL types were: B1 (41.3%, 78.9%, 59.9%), B2 (75%, 66.7%, 68.7%), and B3 (46%, 91.7%, 78.6%). Overall accuracy of the JES classification for estimating depth of invasion was 47.5%. Conclusion: The moderate interobserver agreement suggests the JES-IPCL classification may be useful in the Western world, but extensive training is needed. The findings indicate a longer learning curve for accurate ME-NBI image evaluation using the JES classification.

  • Open Access

    Correlation between liver volume drainage and clinical success after endoscopic biliary drainage of hilar malignant obstruction

    by Jennifer Nakamura Ruas, Ernesto Quaresma Mendonça, Luciano Lenz, Gustavo Andrade de Paulo, Ricardo Uemura Sato, José Jukemura, Ulysses Ribeiro Junior, Fauze Maluf-Filho, Bruno Costa Martins


  • TC-325 Superiority in Malignant Gastrointestinal Bleeding: An Individual Patient Data Meta-Analysis of Randomized Trials

    by Ali A. Alali, Rapat Pittayanon, Myriam Martel, Bruno Costa Martins, Majid A. Almadi, Yen-I Chen, Alan N. Barkun

    INTRODUCTION: The efficacy of topical hemostatic agents, recommended for peptic ulcer bleeding, remains poorly characterized in malignant gastrointestinal bleeding (GIB). METHODS: We performed an individual patient data meta-analysis assessing the efficacy of topical hemostatic agents in malignant GIB. The literature was searched using OVID MEDLINE, EMBASE, and ISI Web of Science databases (database inception to November 2023). Only randomized controlled trials (RCTs) comparing topical hemostatic agents with conventional endoscopic modalities in malignant GIB were included. Original RCT patient-level data were obtained. Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines were followed. Quality of the evidence was evaluated using the revised Cochrane risk-of-bias tool and certainty of evidence with the Grading of Recommendations Assessment, Development, and Evaluation approach. The primary outcome was immediate hemostasis; secondary outcomes were 30-day rebleeding and the composite measure of further bleeding (persistent bleeding or 30-day rebleeding). Other outcomes were all-cause mortality, adverse events, and need for additional nonendoscopic treatment. Odds ratios (ORs) from endpoint comparisons were pooled using logistic regression models. RESULTS: Overall, 985 citations were identified; 3 RCTs (n = 160 patients) were included with all assessing TC-325 (Hemospray). TC-325 achieved immediate hemostasis more often than conventional endoscopic modalities (OR 46.6, 95% confidence interval [CI] 5.89–369.1) (low-level certainty). Thirty-day rebleeding (OR 0.28, 95% CI 0.11–0.70) and further bleeding (OR 0.11, 95% CI 0.05–0.26) were both significantly lower with TC-325 (very-low-level certainty). All-cause mortality and need for additional nonendoscopic treatment did not differ between groups. No adverse events were reported. Subgroup analysis confirmed TC-325 superiority in patients with upper GIB. DISCUSSION: TC-325 seems superior to conventional endoscopic therapy in managing patients with malignant GIB. TC-325 results in improvements in immediate hemostasis, 30-day rebleeding, and further bleeding, based on very low-to-low certainties of evidence.


  • Open Access

    Endoscopic full-thickness resection of type 1 gastric neuroendocrine tumor: step-by-step description of technique

    by Rafael Sartori Balbinot, Diego Cadena, Bruno Costa Martins, Cesar Capel de Clemente Junior, Evandro Sobroza de Mello, Adriana Vaz Safatle-Ribeiro, Fauze Maluf-Filho

    A 47-year-old woman with autoimmune chronic gastritis and type 1 gastric neuroendocrine tumor (gNET) was referred for resection of a gastric subepithelial lesion (SEL). Esophagogastroduodenoscopy showed atrophic pangastritis and a 13-mm SEL located at the anterior wall that was evaluated by endoscopic ultrasound ([Fig. 1], [Fig. 2]). Endoscopic full-thickness resection (EFTR) was adopted. The technical description is demonstrated in [Video 1]. The lesion was delimited with the marking probe. Then, another gastroscope previously mounted with the full-thickness resection device (FTRD) was used to perform the resection ([Fig. 3]). The lesion was caught using the grasper. It was then necessary to apply suction to fully accommodate the lesion in the cap. Once the lesion was completely inside the cap, the clip was released by the handwheel, the snare was closed, and electrocautery was applied (VIO 300, AUTOCUT 100; Erbe Elektromedizin Gmbh, Tübingen, Germany). The patient had an uneventful recovery and was discharged on the first postoperative day. Histopathology confirmed a grade 2 well-differentiated neuroendocrine tumor involving the deepest third of the submucosa with free horizontal and vertical margins ([Fig. 4]). EFTR is an emerging resection technique that allows resection of epithelial or subepithelial neoplastic lesions that affect the muscularis propria or are associated with fibrosis and not eligible for mucosectomy or submucosal resection [1]. EFTR appears to be effective for treating neuroendocrine tumors smaller than 10 mm [2] [3], although there may be a greater risk of incomplete resection for SELs measuring 15 mm. The American Gastroenterological Association and some current data suggest that EFTR be limited to lesions smaller than 15 mm [2] [4]. EFTR is a relatively new procedure that holds great potential for the resection of gastrointestinal wall lesions associated with fibrosis or that are embedded in deeper layers. Endoscopy_UCTN_Code_TTT_1AO_2AG_3AF Article published online: 25 October 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany